{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:22:46Z","timestamp":1790875366213,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2020-5213"],"award-info":[{"award-number":["2020-5213"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.labinv.2023.100301","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T15:18:37Z","timestamp":1702307917000},"page":"100301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma"],"prefix":"10.1016","volume":"104","author":[{"given":"Sridhar","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuman","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1831-9063","authenticated-orcid":false,"given":"Nuzhat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/cco.2019.07.03","article-title":"Management of gallbladder cancer in India","volume":"8","author":"Acharya","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.labinv.2023.100301_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103328","article-title":"Chemotherapy for advanced gallbladder cancer (GBC): a systematic review and meta-analysis","volume":"163","author":"Azizi","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"10.1016\/j.labinv.2023.100301_bib4","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/cancers13225671","article-title":"Molecular targets and emerging therapies for advanced gallbladder cancer","volume":"13","author":"Canale","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2023.100301_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1176935120922154","article-title":"Identification of altered genes in gallbladder cancer as potential driver mutations for diagnostic and prognostic purposes: a computational approach","volume":"19","author":"D\u2019Afonseca","year":"2020","journal-title":"Cancer Inform"},{"key":"10.1016\/j.labinv.2023.100301_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/OTT.S297643","article-title":"Promising molecular targets for the targeted therapy of biliary tract cancers: an overview","volume":"14","author":"Yang","year":"2021","journal-title":"OncoTargets Ther"},{"issue":"6","key":"10.1016\/j.labinv.2023.100301_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hbpd.2022.03.004","article-title":"The efficacy and safety of endoscopic ultrasound-guided fine-needle biopsy in gallbladder masses","volume":"22","author":"Tong","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"17","key":"10.1016\/j.labinv.2023.100301_bib8","article-title":"The emerging role of cell-free DNA as a molecular marker for cancer management","volume":"17","author":"Bronkhorst","year":"2019","journal-title":"Biomol Detect Quantif"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med"},{"issue":"11","key":"10.1016\/j.labinv.2023.100301_bib10","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/cancers12113370","article-title":"Biliary tract cancers: molecular heterogeneity and new treatment options","volume":"12","author":"Personeni","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.labinv.2023.100301_bib11","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","article-title":"Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes","volume":"184","author":"Dentro","year":"2021","journal-title":"Cell"},{"issue":"224","key":"10.1016\/j.labinv.2023.100301_bib12","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early-and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.21873\/cgp.20203","article-title":"Circulating tumor DNA in biliary tract cancer: current evidence and future perspectives","volume":"17","author":"Rizzo","year":"2020","journal-title":"Cancer Genomics Proteomics"},{"issue":"9","key":"10.1016\/j.labinv.2023.100301_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"36","key":"10.1016\/j.labinv.2023.100301_bib15","doi-asserted-by":"crossref","first-page":"58007","DOI":"10.18632\/oncotarget.11157","article-title":"Therapeutic implication of HER2 in advanced biliary tract cancer","volume":"7","author":"Nam","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jjco\/hyy011","article-title":"PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay","volume":"48","author":"Sakamoto","year":"2018","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib18","first-page":"549","article-title":"Bile cell-free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer","volume":"42","author":"Shen","year":"2019","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12253-016-0087-0","article-title":"Quantification of circulating free DNA as a diagnostic marker in gall bladder cancer","volume":"23","author":"Kumari","year":"2017","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.labinv.2023.100301_bib20","first-page":"925","article-title":"Diagnostic value of circulating free DNA\u00a0integrity and global methylation status in gall bladder carcinoma","volume":"25","author":"Kumari","year":"2019","journal-title":"Pathol\u00a0Oncol Res"},{"key":"10.1016\/j.labinv.2023.100301_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153806","article-title":"Genomic profiling of gallbladder carcinoma: targetable mutations and pathways involved","volume":"232","author":"Mishra","year":"2022","journal-title":"Pathol Res Pract"},{"issue":"8","key":"10.1016\/j.labinv.2023.100301_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.labinv.2023.100301_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.annonc.2022.09.150","article-title":"The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer","volume":"33","author":"Berchuck","year":"2022","journal-title":"An Oncol"},{"issue":"18","key":"10.1016\/j.labinv.2023.100301_bib24","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.3390\/cancers13184581","article-title":"Liquid biopsy from bile-circulating tumor DNA in patients with biliary tract cancer","volume":"13","author":"Han","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.labinv.2023.100301_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/15384047.2018.1456604","article-title":"Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer","volume":"19","author":"Kinugasa","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.labinv.2023.100301_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00324","article-title":"Circulating tumor DNA profiling of advanced biliary tract cancers","volume":"3","author":"Mody","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.labinv.2023.100301_bib27","series-title":"WHO classification","author":"Gonzalez","year":"2020"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5858\/2000-124-0037-PFTEOS","article-title":"Protocol for the examination of specimens from patients with carcinomas of the gallbladder, including those showing focal endocrine differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists","volume":"124","author":"Henson","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/modpathol.2010.234","article-title":"Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor","volume":"24","author":"Dahlin","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.labinv.2023.100301_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jclinpath-2015-203403","article-title":"Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases","volume":"69","author":"Malapelle","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"issue":"37","key":"10.1016\/j.labinv.2023.100301_bib31","doi-asserted-by":"crossref","first-page":"40026","DOI":"10.18632\/oncotarget.5432","article-title":"PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.labinv.2023.100301_bib32","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1158\/1078-0432.CCR-15-2470","article-title":"Circulating cell-free tumor DNA analysis of 50 genes by next-generation sequencing in the prospective MOSCATO trial","volume":"22","author":"Jovelet","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.labinv.2023.100301_bib34","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1158\/1078-0432.CCR-17-3831","article-title":"Validation of a plasma-based comprehensive cancer genotyping assay utilizing orthogonal tissue- and plasma-based methodologies","volume":"24","author":"Odegaard","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.labinv.2023.100301_bib35","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/cncr.33571","article-title":"High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: the Korean Lung Liquid Versus Invasive Biopsy Program","volume":"127","author":"Park","year":"2021","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.labinv.2023.100301_bib36","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/ijms19123733","article-title":"Heterogeneity in colorectal cancer: a challenge for personalized medicine","volume":"19","author":"Molinari","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.labinv.2023.100301_bib37","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/annonc\/mdx804","article-title":"Corrections to \u201cCapturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.\u201d","volume":"29","author":"De Mattos-Arruda","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib38","first-page":"100259","article-title":"Circulating cell-free DNA for cancer early detection","volume":"3","author":"Gao","year":"2022","journal-title":"Innovation (Camb)"},{"issue":"10","key":"10.1016\/j.labinv.2023.100301_bib39","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/annonc\/mdx405","article-title":"Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance","volume":"28","author":"Barata","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib40","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-020-00134-3","article-title":"On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer","volume":"4","author":"Moser","year":"2020","journal-title":"npj Precis Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib43","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1200\/PO.21.00182","article-title":"Dynamic changes of circulating tumor DNA predict clinical outcome in patients with advanced non\u2013small-cell lung cancer treated with immune checkpoint inhibitors","volume":"5","author":"Weber","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-020-0719-6","article-title":"Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer","volume":"12","author":"Zhou","year":"2020","journal-title":"Genome Med"},{"issue":"22","key":"10.1016\/j.labinv.2023.100301_bib45","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1158\/1078-0432.CCR-19-1436","article-title":"Treatment with next-generation ALK inhibitors fuels plasma ALK mutation diversity","volume":"25","author":"Dagogo-Jack","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.labinv.2023.100301_bib46","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1158\/1078-0432.CCR-19-3608","article-title":"Molecular mechanisms of acquired resistance to MET tyrosine kinase inhibitors in patients with MET exon 14-mutant NSCLC","volume":"26","author":"Recondo","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.labinv.2023.100301_bib47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.gastro.2019.10.039","article-title":"Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer","volume":"158","author":"Azad","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.labinv.2023.100301_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol Diagn Ther"},{"issue":"346","key":"10.1016\/j.labinv.2023.100301_bib49","doi-asserted-by":"crossref","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.labinv.2023.100301_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat Cancer"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"6206","key":"10.1016\/j.labinv.2023.100301_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"De Bruin","year":"2014","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.labinv.2023.100301_bib54","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.3390\/cancers13215257","article-title":"Gallbladder cancer: current insights in genetic alterations and their possible therapeutic implications","volume":"13","author":"Kuipers","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/17474124.2021.1896967","article-title":"Next generation sequencing for biliary tract cancers","volume":"15","author":"DiPeri","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.labinv.2023.100301_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8794-7-23","article-title":"Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing","volume":"7","author":"Wong","year":"2014","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41241-019-0075-2","article-title":"Use of uracil-DNA glycosylase enzyme to reduce DNA-related artifacts from formalin-fixed and paraffin-embedded tissues in diagnostic routine","volume":"39","author":"Berra","year":"2019","journal-title":"Appl Cancer Res"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100928","article-title":"Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex\/hemin enzyme","volume":"14","author":"Ying","year":"2021","journal-title":"Transl Oncol"},{"issue":"7","key":"10.1016\/j.labinv.2023.100301_bib59","first-page":"4990","article-title":"Genomic mutation characteristics and prognosis of biliary tract cancer","volume":"14","author":"Guo","year":"2022","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib60","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.labinv.2023.100301_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ags3.12334","article-title":"Genetic analysis in the clinical management of biliary tract cancer","volume":"4","author":"Wakai","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.21037\/jgo.2018.08.18","article-title":"Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets","volume":"10","author":"Weinberg","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.labinv.2023.100301_bib64","first-page":"492","article-title":"Molecular pathogenesis of cholangiocarcinoma: implications for disease classification and therapy","volume":"36","author":"Kabbara","year":"2022","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.07.005","article-title":"Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing","volume":"99","author":"Putra","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"17","key":"10.1016\/j.labinv.2023.100301_bib66","doi-asserted-by":"crossref","first-page":"14744","DOI":"10.18632\/oncotarget.4539","article-title":"Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies","volume":"6","author":"Brandi","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.labinv.2023.100301_bib67","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.labinv.2023.100301_bib68","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.08.027","article-title":"Targeting cholangiocarcinoma","volume":"1864","author":"Mertens","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.labinv.2023.100301_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12253-018-0491-8","article-title":"Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis","volume":"26","author":"Lendvai","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"24","key":"10.1016\/j.labinv.2023.100301_bib71","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/cncr.30254","article-title":"Biliary cancer: utility of next-generation sequencing for clinical management","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.labinv.2023.100301_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.21037\/atm.2019.08.67","article-title":"Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practice","volume":"7","author":"Lin","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.labinv.2023.100301_bib73","article-title":"Gallbladder cancer: current and future treatment options","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Pharmacol"},{"issue":"7691","key":"10.1016\/j.labinv.2023.100301_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature25475","article-title":"HER kinase inhibition in patients with HER2-and HER3-mutant cancers","volume":"554","author":"Hyman","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.labinv.2023.100301_bib75","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib76","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1038\/s41467-021-25012-9","article-title":"Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer","volume":"12","author":"Lin","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib77","first-page":"109","article-title":"Identification of therapeutic targets of gallbladder cancer using multi-omics approach","volume":"22","author":"Ali","year":"2023","journal-title":"Brief Functl Genomics"},{"issue":"2","key":"10.1016\/j.labinv.2023.100301_bib78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/2159-8290.CD-17-1009","article-title":"Blood-based genomic profiling of circulating cell-free tumor DNA (ctDNA) in 1397 patients (pts) with colorectal cancer","volume":"8","author":"Strickler","year":"2018","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.labinv.2023.100301_bib79","article-title":"Genotyping of circulating tumor DNA\u00a0in\u00a0cholangiocarcinoma reveals diagnostic and prognostic information","volume":"9","author":"Ettrich","year":"2019","journal-title":"Sci\u00a0Rep"},{"issue":"5","key":"10.1016\/j.labinv.2023.100301_bib80","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","article-title":"Integrative molecular characterisation of\u00a0gallbladder cancer reveals micro-environment-associated subtypes","volume":"74","author":"Nepal","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.labinv.2023.100301_bib81","doi-asserted-by":"crossref","first-page":"604","DOI":"10.21037\/hbsn.2019.04.11","article-title":"Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients","volume":"8","author":"Yang","year":"2019","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.labinv.2023.100301_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154320","article-title":"Circulating microRNAs in gallbladder cancer: is serum assay of diagnostic value?","volume":"242","author":"Srivastava","year":"2023","journal-title":"Pathol-Res Pract"},{"issue":"7732","key":"10.1016\/j.labinv.2023.100301_bib83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","article-title":"Sensitive tumour detection and classification using plasma cell-free DNA methylomes","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683723002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683723002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:00:51Z","timestamp":1758398451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683723002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0023683723002441"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2023.100301","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2023.100301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100301"}}